Salminen T - Search Results

1

Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.

Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H. Korhonen K, et al. Among authors: salminen t. J Neurooncol. 2006 Oct;80(1):1-7. doi: 10.1007/s11060-006-9146-9. Epub 2006 May 13. J Neurooncol. 2006. PMID: 16703453

2

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J. Joensuu H, et al. Among authors: salminen t. Clin Cancer Res. 2003 Mar;9(3):923-30. Clin Cancer Res. 2003. PMID: 12631589

3

Incidence of gliomas by anatomic location.

Larjavaara S, Mäntylä R, Salminen T, Haapasalo H, Raitanen J, Jääskeläinen J, Auvinen A. Larjavaara S, et al. Among authors: salminen t. Neuro Oncol. 2007 Jul;9(3):319-25. doi: 10.1215/15228517-2007-016. Epub 2007 May 23. Neuro Oncol. 2007. PMID: 17522333 Free PMC article. Clinical Trial.

4

XRCC1 and XRCC3 variants and risk of glioma and meningioma.

Kiuru A, Lindholm C, Heinävaara S, Ilus T, Jokinen P, Haapasalo H, Salminen T, Christensen HC, Feychting M, Johansen C, Lönn S, Malmer B, Schoemaker MJ, Swerdlow AJ, Auvinen A. Kiuru A, et al. Among authors: salminen t. J Neurooncol. 2008 Jun;88(2):135-42. doi: 10.1007/s11060-008-9556-y. J Neurooncol. 2008. PMID: 18330515

5

Pituitary tumor risk in relation to mobile phone use: A case-control study.

Shrestha M, Raitanen J, Salminen T, Lahkola A, Auvinen A. Shrestha M, et al. Among authors: salminen t. Acta Oncol. 2015;54(8):1159-65. doi: 10.3109/0284186X.2015.1045624. Epub 2015 May 18. Acta Oncol. 2015. PMID: 25982941

6

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

Ristimäki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J. Ristimäki A, et al. Among authors: salminen t. Cancer Res. 2002 Feb 1;62(3):632-5. Cancer Res. 2002. PMID: 11830510

7

Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.

Malmer BS, Feychting M, Lönn S, Lindström S, Grönberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C, Kiuru A, Mudie N, Salminen T, Schoemaker MJ, Swerdlow AJ, Henriksson R. Malmer BS, et al. Among authors: salminen t. J Neurooncol. 2007 May;82(3):229-37. doi: 10.1007/s11060-006-9275-1. Epub 2006 Dec 7. J Neurooncol. 2007. PMID: 17151932

8

Mobile phone use and risk of glioma in 5 North European countries.

Lahkola A, Auvinen A, Raitanen J, Schoemaker MJ, Christensen HC, Feychting M, Johansen C, Klaeboe L, Lönn S, Swerdlow AJ, Tynes T, Salminen T. Lahkola A, et al. Among authors: salminen t. Int J Cancer. 2007 Apr 15;120(8):1769-75. doi: 10.1002/ijc.22503. Int J Cancer. 2007. PMID: 17230523 Free article.

9

Selection bias due to differential participation in a case-control study of mobile phone use and brain tumors.

Lahkola A, Salminen T, Auvinen A. Lahkola A, et al. Among authors: salminen t. Ann Epidemiol. 2005 May;15(5):321-5. doi: 10.1016/j.annepidem.2004.12.009. Ann Epidemiol. 2005. PMID: 15840544

10

Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997.

Klaeboe L, Lonn S, Scheie D, Auvinen A, Christensen HC, Feychting M, Johansen C, Salminen T, Tynes T. Klaeboe L, et al. Among authors: salminen t. Int J Cancer. 2005 Dec 20;117(6):996-1001. doi: 10.1002/ijc.21255. Int J Cancer. 2005. PMID: 15986431 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page